Recombinant multi-species RIC8A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RIC8A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Predicted to enable G-protein alpha-subunit binding activity; GTPase activator activity; and guanyl-nucleotide exchange factor activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Predicted to act upstream of or within several processes, including basement membrane organization; gastrulation; and visual learning. Predicted to be located in membrane. Predicted to be active in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: Chaperone Ric-8A,RIC-8,RIC8,RIC8A,Ric-8A,Ric8,Ric8a,Synembryn-A

Target products collectionGo to RIC8A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T14196-Ag-1/ GM-Tg-hg-T14196-Ag-2 Human RIC8A protein Human
GM-Tg-rg-T14196-Ag-1/ GM-Tg-rg-T14196-Ag-2 Rat RIC8A protein Rat
GM-Tg-mg-T14196-Ag-1/ GM-Tg-mg-T14196-Ag-2 Mouse RIC8A protein Mouse
GM-Tg-cynog-T14196-Ag-1/ GM-Tg-cynog-T14196-Ag-2 Cynomolgus/Rhesus macaque RIC8A protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T14196-Ag-1/ GM-Tg-felg-T14196-Ag-2 Feline RIC8A protein Feline
GM-Tg-cang-T14196-Ag-1/ GM-Tg-cang-T14196-Ag-2 Canine RIC8A protein Canine
GM-Tg-bovg-T14196-Ag-1/ GM-Tg-bovg-T14196-Ag-2 Bovine RIC8A protein Bovine
GM-Tg-equg-T14196-Ag-1/ GM-Tg-equg-T14196-Ag-2 Equine RIC8A protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T14196-Ag-1/ GM-Tg-hg-T14196-Ag-2; GM-Tg-rg-T14196-Ag-1/ GM-Tg-rg-T14196-Ag-2;
GM-Tg-mg-T14196-Ag-1/ GM-Tg-mg-T14196-Ag-2; GM-Tg-cynog-T14196-Ag-1/ GM-Tg-cynog-T14196-Ag-2;
GM-Tg-felg-T14196-Ag-1/ GM-Tg-felg-T14196-Ag-2; GM-Tg-cang-T14196-Ag-1/ GM-Tg-cang-T14196-Ag-2;
GM-Tg-bovg-T14196-Ag-1/ GM-Tg-bovg-T14196-Ag-2; GM-Tg-equg-T14196-Ag-1/ GM-Tg-equg-T14196-Ag-2
Products Name RIC8A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RIC8A
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RIC8A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.